Claims
- 1. A process for the preparation of a substituted benzo(chalcogeno)[4,3,2-cd]indazole of the formula ##STR19## or a pharmaceutically acceptable salt thereof, wherein X is oxygen, sulfur, or selenium;
- D is a straight or branched alkylene group of from two to eight carbon atoms;
- D' is ethylene;
- R.sub.1 and R.sub.2 may be the same or different and are hydrogen or an alkyl group of from two to eight carbon atoms which may be substituted by hydroxy; and
- R.sub.3, R.sub.4, R.sub.5, and R.sub.6 may be the same or different and are hydrogen or hydroxy which comprises:
- (a) reacting an alkyl-substituted compound of the formula ##STR20## wherein X, R.sub.1, R.sub.2, and D are as described above, Z is an alkyl of from one to four carbon atoms, and n is an integer of from one to four;
- with excess boron tribromide in a suitable organic solvent then with methanol to give a hydroxylated compound of the Formula ##STR21## wherein X, n, D, R.sub.1, and R.sub.2 are as described above; (b) reacting a compound of Formula 3 with the N-acylimidazole derived from the reaction of 1,1'-carbonyldiimazole and N-trityl glycine, or N-trityl alanine in N,N-dimethylformamide to give a salt of the corresponding trityl-protected amino acid compound of Formula ##STR22## wherein X.sub.1, R.sub.1, R.sub.2, D, and n are as described above, Q is a methylene group, and Tr is C(C.sub.6 H.sub.5).sub.3 ;
- (c) precipitating a salt of a compound of Formula 4A above and recovering a compound of Formula 4A;
- (d) reducing the carbonyl portion of a compound of Formula 4A to the corresponding methylene-containing compound of Formula 5A ##STR23## (e) purifying a compound of Formula 5A by recrystallization; (f) removing the trityl-protecting group from a compound of Formula 5A by reaction with an acid to produce a compound of the instant invention of Formula 1 above.
- 2. The process of claim 1 wherein in Step (a) the reactants are boron tribromide and methanol.
- 3. The process of claim 1 wherein in Step (a) the reaction time is from 15 to 20 hours at a temperature of from 50.degree. to 65.degree. C.
- 4. The process of claim 1 wherein in Step (a) n is 1 and Z is methyl.
- 5. The process of claim 1 wherein in Step (a) the alkoxy substituted compound is 5-amino-N,N-diethyl-8-methoxy-2H-[1]benzo(chalcogeno)-[4,3,2-cd]indazole-2-ethanamine.
- 6. The process of claim 1 wherein in Step (a) X is sulfur.
- 7. The process of claim 1 wherein in Step (a) the organic solvent is a mixture of dichloromethane and 1,2-dichloroethane in a ratio of 1:1.
- 8. The process of claim 1 wherein in Step (b) the ratio of a compound of Formula 3 to reactants 1,1'-carbonyldiimidazole and N-trityl-glycine is from 1:2:2 to 1:3:3.
- 9. The process of claim 1 wherein in Step (c) the precipitating agent is water and recovering of compound 4A proceeds by triethylamine in methanol-ethyl acetate mixture.
- 10. The process of claim 1 wherein in Step (d) the reducing agent is sodium bis(2-methoxyethoxy)aluminum hydride.
- 11. The process of claim 1 wherein in Step (d) the reduction takes place in toluene and the product is extracted with ethyl acetate and then with an ethyl acetate-tetrahydrofuran mixture in a ratio of 4:1 to 1:1.
- 12. The process of claim 1 wherein in Step (e) the purifying agent is methanol, acetonitrile, and ethylacetate in a ratio of from 1:1:1 to 1:1:2.
- 13. The process of claim 1 wherein in Step (f) the reaction mixture is a two-phase mixture of dichloromethane and trifluoroethanol in a ratio of 2:1 and water.
- 14. The process of claim 1 wherein in Step (f) the reaction time is from 30 minutes to 90 minutes at room temperature.
- 15. The process of claim 1 wherein in Step (f) the acid is hydrochloric.
- 16. The process of claim 1 wherein the compound produced is 5-[(2-aminoethyl)amino]-2-[2-(diethylamino)ethyl]-2H-[1]benzothiopyrano[4,3,2-cd]-indazol-8-ol, trihydrochloride.
- 17. The process of claim 1 wherein the compound produced is 5-[(2-aminoethyl)amino]-2-[2-(diethylamino)ethyl]-2H-[1]benzothipyrano[4,3,2-cd]indazol-9-ol, trihydrochloride.
- 18. A compound named N-[2[2-(diethylamino)ethyl]8-hydroxy-2H-[1]benzothiopyrano[4,3,2-cd]indazol-5-yl-2-[(triphenylmethyl)amino]acetamide.
- 19. A compound named 2-[2-(diethylamino)ethyl]-5-[(2-(triphenylmethyl)aminoethyl]amino-2H-[1]benzothiopyrano[4,3,2-cd]indazol-8-ol.
- 20. A compound named N-[2[2-(diethylamino)ethyl]-9-hydroxy-2H-[1]-benzothiopyrano[4,3,2-cd]indazol-5-yl-2-[(triphenylmethyl)amino]acetamide.
- 21. A compound named 2-[2-(diethylamino)ethyl]-5-[(2-(triphenylmethyl)aminoethyl]amino-2H-[1]-benzothiopyrano[4,3,2-cd]indazol-9-ol.
Parent Case Info
This is a continuation-in-part of U.S. Application Ser. No. 029,021 filed Mar. 23, 1987 now abandoned.
US Referenced Citations (1)
Number |
Name |
Date |
Kind |
4604390 |
Elslager et al. |
Aug 1986 |
|
Continuation in Parts (1)
|
Number |
Date |
Country |
Parent |
29021 |
Mar 1987 |
|